Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Mcguinness, Serena

  • Google
  • 1
  • 5
  • 6

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (1/1 displayed)

  • 2023What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials6citations

Places of action

Chart of shared publication
Chalder, Trudie
1 / 5 shared
Watson, Natalie
1 / 1 shared
Norton, Christine
1 / 2 shared
King, Kathryn
1 / 2 shared
Czuber-Dochan, Wladyslawa
1 / 1 shared
Chart of publication period
2023

Co-Authors (by relevance)

  • Chalder, Trudie
  • Watson, Natalie
  • Norton, Christine
  • King, Kathryn
  • Czuber-Dochan, Wladyslawa
OrganizationsLocationPeople

article

What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials

  • Chalder, Trudie
  • Watson, Natalie
  • Norton, Christine
  • King, Kathryn
  • Mcguinness, Serena
  • Czuber-Dochan, Wladyslawa
Abstract

Purpose:<br/>Between 53–75% of people with inflammatory bowel disease, 30-80% with rheumatoid arthritis and up to 50% with multiple sclerosis do not take medications as prescribed to maintain remission. This scoping review aimed to identify effective adherence interventions for inflammatory bowel disease, but with few studies found, multiple sclerosis and rheumatoid arthritis were included to learn lessons from other conditions.<br/><br/>Patients and methods: <br/>Full and pilot randomised controlled trials testing medication adherence interventions for inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis conducted between 2012-2021, were identified in six electronic databases. <br/><br/>Results:<br/>3024 participants were included from 24 randomised controlled trials; ten pilot and 14 full studies. Eight investigated inflammatory bowel disease, 12 rheumatoid arthritis and four multiple sclerosis. Nine studies (37.5%) reported significantly improved medication adherence; all involving tailored, personalised education, advice or counselling by trained health professionals, with five delivered face-to-face and 1:1.Quality of effective interventions was mixed; five rated high quality, two medium and two low quality.<br/>Interventions predominantly using technology were likely to be most effective.Secondary tools such as diaries, calendars and advice-sheets were also efficient in increasing adherence. Only 10 interventions were based on an adherence theory, of which four significantly improved adherence.<br/><br/>Conclusions:<br/>Tailored, face to face, 1:1 interaction with healthcare professionals were successful at providing personalised adherence support.Accessible, user-friendly technology-based tools supported by calendars and reminders effectively enhanced adherence. <br/>Key components of effective interventions should be evaluated and integrated further into clinical practice if viable, whilst being tailored to inflammatory conditions.

Topics
  • theory